InvestorsHub Logo
Followers 698
Posts 59465
Boards Moderated 18
Alias Born 06/01/2008

Re: None

Thursday, 10/29/2020 11:55:42 PM

Thursday, October 29, 2020 11:55:42 PM

Post# of 301
How is this possible?

"Kontrol currently has approximately $3.0 Million of cash on hand as of October 28th, 2020 and has sufficient resources to complete the commercialization of BioCloud."

Who stated this?

"It is a given that BioCloud will have the ability to treat subsequent viruses as they occur."

Kontrol establishes lower detection limit for
commercialization of BioCloud

- Kontrol BioCloud a Safe Space Technology -

TORONTO, ON / October 29th, 2020 / Kontrol Energy Corp. (CSE:KNR) (OTCQB:KNRLF)
(FSE:1K8) ("Kontrol" or "Company") is pleased to provide an update on its Kontrol BioCloud
(or "BioCloud") technology. As initially referenced in the press release from September 10,
2020 Kontrol is providing an update on lower detection limits and commercialization.

Lower Detection Limit

"We are pleased to continue to advance towards the production of BioCloud units in
November,” says Paul Ghezzi, CEO Kontrol.

“The lower detection limit is an important
benchmark to provide potential customers with the operating sensitivity of BioCloud.”

As part of its commercialization of the BioCloud technology, Kontrol has currently
established a lower detection limit of 50 SARs-COV-2 virus particles.

This represents a
sufficient sensitivity to the SARS COV-2 virus for commercialization.

The determination of lower detection limit was tested under independent laboratory
conditions over multiple tests.

The BioCloud virus collector was exposed to live SARs-COV2 virus (virus that causes COVID-19) at multiple levels of virus ranging from 10,000, 5,000,
1,000, 100, 50 and 5 viruses.

These tests were conducted multiple times to ensure
repeatability of the response, and under laboratory conditions the detection of the live
SARs-COV-2 virus was repeatably identified at 50 virus particles.

Commercialization

Based on feedback from potential customers and potential distribution channels Kontrol is
seeking multiple certifications concurrently to meet regional requirements.

These include
CSA, CE and UL. CSA is a Canadian certification; CE mainly applies to European electro nic
products and UL is typically required in the USA.

Balance Sheet

Kontrol currently has approximately $3.0 Million of cash on hand as of October 28 th, 2020
and has sufficient resources to complete the commercialization of BioCloud.
National Research Council of Canada
Kontrol has submitted all of its required research and files for potential National Research
Council of Canada funding.
About Kontrol BioCloud
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed
to operate as a safe space technology by sampling the air quality over time. With a
proprietary detection chamber that can be replaced as needed, viruses are detected, and
an alert system is created in the Cloud or over local intranet. BioCloud has been designed
for spaces where individuals gather including classrooms, retirement homes, hospitals,
mass transportation and others. It can be an important technology which supports the
entire system of individual testing and contact tracing.
The Company is not making any express or implied claims that its product has the ability
to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).
About Kontrol Energy
Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is a leader in the energy
efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and
acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides marketbased energy solutions to our customers designed to reduce their overall cost of energy
while providing a corresponding reduction in greenhouse gas (GHG) emissions.
Additional information about Kontrol Energy Corp. can be found on its we